AXON Axon Enterprise Inc

Price (delayed)

$232.34

Market cap

$17.41B

P/E Ratio

116.75

Dividend/share

N/A

EPS

$1.99

Enterprise value

$17.72B

Axon Enterprise, Inc. is a Scottsdale, Arizona-based company which develops technology and weapons products for law enforcement and civilians. Its initial product and former namesake is Taser, a line of ...

Highlights
The net income has grown by 48% since the previous quarter and by 40% year-on-year
AXON's EPS is up by 45% since the previous quarter and by 36% year-on-year
Axon Enterprise's quick ratio has increased by 24% YoY but it has decreased by 5% from the previous quarter
AXON's P/E is 6% above its last 4 quarters average of 109.9

Key stats

What are the main financial stats of AXON
Market
Shares outstanding
74.93M
Market cap
$17.41B
Enterprise value
$17.72B
Valuations
Price to book (P/B)
11.42
Price to sales (P/S)
11.85
EV/EBIT
132.28
EV/EBITDA
104.61
EV/Sales
12.07
Earnings
Revenue
$1.47B
EBIT
$133.93M
EBITDA
$169.34M
Free cash flow
$133.27M
Per share
EPS
$1.99
Free cash flow per share
$1.78
Book value per share
$20.35
Revenue per share
$19.61
TBVPS
$42.45
Balance sheet
Total assets
$3.25B
Total liabilities
$1.73B
Debt
$711.64M
Equity
$1.52B
Working capital
$1.54B
Liquidity
Debt to equity
0.47
Current ratio
3.15
Quick ratio
2.28
Net debt/EBITDA
1.8
Margins
EBITDA margin
11.5%
Gross margin
61.1%
Net margin
10%
Operating margin
9.2%
Efficiency
Return on assets
4.8%
Return on equity
10.4%
Return on invested capital
5%
Return on capital employed
5.3%
Return on sales
9.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXON stock price

How has the Axon Enterprise stock price performed over time
Intraday
0.27%
1 week
2.87%
1 month
7.14%
1 year
37.13%
YTD
40.02%
QTD
16.76%

Financial performance

How have Axon Enterprise's revenue and profit performed over time
Revenue
$1.47B
Gross profit
$897.17M
Operating income
$134.52M
Net income
$146.13M
Gross margin
61.1%
Net margin
10%
The operating margin has surged by 124% year-on-year and by 12% since the previous quarter
The net income has grown by 48% since the previous quarter and by 40% year-on-year
AXON's net margin is up by 39% QoQ and by 3.1% YoY
Axon Enterprise's revenue has increased by 37% YoY and by 7% from the previous quarter

Growth

What is Axon Enterprise's growth rate over time

Valuation

What is Axon Enterprise stock price valuation
P/E
116.75
P/B
11.42
P/S
11.85
EV/EBIT
132.28
EV/EBITDA
104.61
EV/Sales
12.07
AXON's EPS is up by 45% since the previous quarter and by 36% year-on-year
AXON's P/E is 6% above its last 4 quarters average of 109.9
AXON's P/B is 39% above its 5-year quarterly average of 8.2 and 12% above its last 4 quarters average of 10.2
The equity has grown by 24% YoY and by 5% from the previous quarter
Axon Enterprise's revenue has increased by 37% YoY and by 7% from the previous quarter
The price to sales (P/S) is 21% more than the 5-year quarterly average of 9.8 and 9% more than the last 4 quarters average of 10.9

Efficiency

How efficient is Axon Enterprise business performance
Axon Enterprise's ROIC has plunged by 56% YoY but it has increased by 35% from the previous quarter
AXON's return on sales is up by 44% since the previous quarter but it is down by 22% year-on-year
AXON's return on equity is up by 41% since the previous quarter and by 14% year-on-year
Axon Enterprise's ROA has increased by 33% from the previous quarter but it has decreased by 14% YoY

Dividends

What is AXON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXON.

Financial health

How did Axon Enterprise financials performed over time
The company's total assets is 88% higher than its total liabilities
The total liabilities has surged by 122% year-on-year and by 6% since the previous quarter
The company's total assets has surged by 62% YoY and by 6% QoQ
AXON's debt is 53% lower than its equity
The equity has grown by 24% YoY and by 5% from the previous quarter
The debt to equity has contracted by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.